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Abstract 
Background: Retinal microvascular imaging is an especially promising application of high resolution imaging since 
there are increasing options for therapeutic intervention and need for better structural and functional biomarkers to 
characterize ocular and systemic vascular diseases.
Main body: Adaptive optics scanning light ophthalmoscopy (AOSLO) is an emerging technology for improving 
in vivo imaging of the human retinal microvasculature, allowing unprecedented visualization of retinal microvascular 
structure, measurements of blood flow velocity, and microvascular network mapping. This high resolution imaging 
technique shows significant potential for studying physiological and pathological conditions of the retinal microvas-
culature noninvasively.
Conclusion: This review will briefly summarize the abilities of in vivo human retinal microvasculature imaging in 
healthy controls, as well as patients with diabetic retinopathy, retinal vein occlusion, and sickle cell retinopathy using 
AOSLO and discuss its potential contribution to scientific research and clinical applications.
Keywords: Retina, Adaptive optics, Blood vessels, Capillaries, Diabetic retinopathy, Sickle cell retinopathy, Retinal vein 
occlusion, Fluorescein angiography
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Background
The retina has one of the highest metabolic demands per 
unit weight of any tissue in the human body [1], making 
it especially vulnerable to disease processes that damage 
the vascular network and lessen the oxygen and nutri-
ent supply to the tissue. The ability to detect these dis-
ease manifestations early is important as it offers the 
opportunity to intervene systemically as well as locally in 
order to slow, stop or even reverse these changes. Macro-
scopic features of the retinal vasculature, such as arteri-
olar narrowing, arteriovenous nicking, hemorrhages and 
microaneurysms have traditionally been used as signs of 
progressive cardiovascular disease, as well as hyperten-
sion and diabetes mellitus. Studying microscopic features 
of the retinal vasculature would theoretically enable ear-
lier detection of disease. Thus, our ability to image reti-
nal microvasculature is important for providing better 
knowledge of the normal physiological retina and patho-
logical process, allowing development of new strategies 
to prevent or delay disease progression.
Recently, advances in high resolution imaging tech-
niques such as adaptive optics and optical coherence 
tomography angiography (OCTA) have expanded our 
ability to map the living human retinal vasculature non-
invasively without the use of exogenous contrast agents 
[2–8]. In particular, adaptive optics scanning light oph-
thalmoscopy (AOSLO) is an emerging technology for 
the visualization of microscopic structures in the living 
human retina to an extent that had not been previously 
possible with conventional clinical imaging modalities 
[9]. This imaging technique utilizes deformable mirrors 
to correct for ocular aberrations, allowing high resolution 
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non-invasive imaging of retinal structures including reti-
nal nerve fibers, retinal microvasculature, photorecep-
tors, retinal pigment epithelium, and lamina cribrosa [4, 
9–18]. Specifically, the non-invasive nature of AOSLO 
imaging makes it very appealing for screening, detect-
ing, and monitoring subclinical microvascular changes in 
the human retina, which may enable earlier intervention 
against retinal diseases.
Review
AOSLO imaging with confocal and nonconfocal detection 
schemes
Confocal detection schemes
Traditionally, confocal AOSLO has allowed direct visu-
alization of microscopic structures of the human retina 
with unprecedented contrast and resolution [9, 10, 13, 
14, 19]. This confocal imaging technique is achieved by 
placing a spatial pinhole at a retinal conjugate plane to 
include only direct backscattered light and eliminate 
multiply scattered light (out-of-focus) simultaneously. 
Non-invasive assessment of the retinal microvascular 
network using confocal AOSLO has been demonstrated 
on healthy and diseased retinas [3, 18, 20]. This technique 
has been applied successfully at the foveal region (Fig. 1a) 
where there is simpler anatomy and few capillary layers. 
It has limited success, however, more peripherally where 
the capillary meshwork is more complex, such as in the 
peripapillary and perifoveal regions. In addition, the 
strong direct backscattering signal from highly reflective 
tissues, such as the retinal nerve fiber layer and glial cells, 
masks the backscattered light from microvasculature, 
making it more difficult to image using this technique in 
the periphery [16]. Fluorescein angiography (FA), cou-
pled with confocal AOSLO, has enhanced the success 
of imaging the retinal microvasculature of the macula 
(Fig. 1b) and peripapillary retina [21, 22]. Although con-
focal AOSLO FA is considered safe and has been used 
to show perfusion and non-perfusion of the retinal cap-
illaries in healthy controls and patients with vasculopa-
thies [23–25], it requires an additional light source for 
fluorescein excitation and administration of oral fluores-
cein, making it more invasive with some risk of patient 
Fig. 1 Visualization of foveal capillary network and foveal avascular zone in a 25-year-old healthy male control (RR0188) using different imaging 
modalities. a Confocal AOSLO structural image, b confocal AOSLO FA perfusion map, c nonconfocal AOSLO structural image, d motion contrast 
perfusion map generated using registered nonconfocal AOSLO structural movies, and e OCTA imaged using Optovue RTVue XR Avanti (AngioVue, 
Optovue, Inc., Fremont, CA)
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discomfort and potential side effects such as nausea and 
itching.
Nonconfocal detection schemes
Recently, the options of adaptive optics microscopic 
imaging have been expanded through the use of multiply 
scattered light with nonconfocal detection schemes (e.g. 
offset pinhole, dark field, and split detection). The general 
principles and applications of this technique have been 
described in detail elsewhere [15, 16, 26–30]. Several 
studies have demonstrated that multiply scattered light, 
which is systematically removed in confocal AOSLO 
imaging, contains valuable information about the retina. 
Detection of multiply scattered light allows non-invasive 
visualization of retinal vascular structures using reflec-
tance imaging (Fig. 1c) and provides microvascular per-
fusion maps through the use of motion contrast image 
processing (Fig. 1d) [2, 12, 16, 29, 31]. Microvascular per-
fusion maps are generated by extraction of moving ele-
ments from registered nonconfocal AOSLO videos, such 
as the intravascular flow of erythrocytes against the back-
ground of static tissue [2]. Nonconfocal AOSLO imaging 
provides structural images and perfusion maps compara-
ble to those of confocal AOSLO FA with additional struc-
tural information such as fine structural components of 
vascular walls [22]. Figure 2 shows in vivo visualization of 
retinal vascular mural cells (Fig. 2a, b) and motion con-
trast perfusion maps (Fig. 2c, d) in arterioles and venules 
using nonconfocal AOSLO. Connections between arteri-
oles and venules at the fovea and the temporal retina are 
readily seen on widefield motion contrast perfusion maps 
created by montaging as illustrated in Fig. 3. 
Comparison of perfusion maps—IVFA, AOSLO, and OCTA
Since it was introduced by Novotny and Alvis in 1961, 
intravenous fluorescein angiography (IVFA) has been 
the clinical gold standard for assessing retinal vascular 
disease [32]. It produces an analyzable picture of the ret-
inal vasculature in  vivo and is able to detect pathologi-
cal features such as non-perfusion, infarctions, edema, 
neovascularization, microaneurysms and leakage at 
blood–retinal barrier ruptures [21, 33]. It has helped 
with diagnosis, as well directing treatment of a vari-
ety of conditions ranging from diabetic macular edema 
to retinopathy of prematurity [34, 35]. While IVFA has 
fostered many discoveries about retinal vasculopathies, 
it has some limitations. It offers a widefield view of the 
vasculature, but has inherent limitations in axial and lat-
eral resolution. IVFA has difficulty revealing capillaries 
with smaller diameters, and those that are anatomically 
deeper and further from the fovea, as suggested by exam-
ination of comparable flat-mounted histological sections 
[36]. In addition, there is concern about the invasive 
nature of IVFA due to the use of an exogenous contrast 
agent, which occasionally produces minor reactions such 
as nausea and pruritus, and much more rarely anaphy-
laxis and death [37–41].
Confocal AOSLO FA performed with oral administra-
tion of fluorescein has an ability to image the microscopic 
detail of the retinal vasculature with greater resolution 
and contrast than with conventional imaging [21]. Com-
parisons of IVFA and confocal AOSLO FA perfusion map 
in a healthy control and a patient with proliferative dia-
betic retinopathy are included in Figs.  4 and 5, respec-
tively. Confocal AOSLO FA offers great potential for 
precise quantification of the foveal avascular zone, ves-
sel lumen diameters, branching patterns, capillary den-
sity and tortuosity in both healthy and diseased retinas. 
Oral administration of fluorescein with confocal AOSLO 
FA enables extended fluorescein imaging time with lower 
risk of side effects, but the small imaging field of view of 
confocal AOSLO FA necessitates montaging to create 
larger perfusion maps. 
Nonconfocal AOSLO coupled with motion contrast 
processing reveals maps of retinal microvasculature per-
fusion with detail comparable to confocal AOSLO FA, 
but without the need for any exogenous contrast agent 
[22]. This image processing technique takes advantage of 
the motion of multiply scattering particles, in this case, 
intravascular erythrocytes, which serve as intrinsic mark-
ers revealing the perfusion status of retinal microvascula-
ture [2, 29]. Limitations of this technique include motion 
artifacts, inability to visualize fluorescein leakage or pool-
ing, and difficulty in detecting blood vessels with slow or 
intermittent perfusion in comparison to IVFA and confo-
cal AOSLO FA.
OCTA imaging is a new and emerging technology 
based on motion contrast with widespread clinical 
potential for mapping the retinal vasculature, detecting 
retinal vascular abnormalities and monitoring disease 
progression (Fig.  1e). Similar to nonconfocal AOSLO, 
OCTA is completely non-invasive, not requiring an 
exogenous contrast agent. In comparison to adaptive 
optics imaging techniques, OCTA’s major advantage is 
the much shorter imaging time. OCTA also has a major 
advantage over IVFA or confocal AOSLO FA, since it 
is able to delineate the different layers of retinal capil-
lary beds including the choriocapillaris in a single scan 
[22]. However, since it relies on motion contrast, it is 
subject to projection artifacts from more superficial 
vessels shadowing upon the deeper layer vessels, more 
prone to motion artifacts, and is unable to show leak-
age or slowed perfusion. Both nonconfocal AOSLO and 
OCTA provide attractive alternatives to IVFA or confo-
cal AOSLO FA, since they allow frequent non-invasive 
evaluation and follow up exams.
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Despite their advantages, AOSLO and OCTA are 
relatively new to the clinic and not yet considered rou-
tine techniques for imaging retinal vasculature. As with 
any new technology, the accuracy and reproducibility of 
AOSLO and OCTA must be tested in order to establish 
their validity and suitability for routine clinical imple-
mentation. These investigations are especially critical 
prior to initiation of cross-sectional or longitudinal stud-
ies of pathological microvascular change. Since accu-
racy and reproducibility have yet to be established, such 
Fig. 2 In vivo imaging of human retinal vascular wall fine structures in arterioles and venules using nonconfocal AOSLO. Structural images of a ven-
ule and b an arteriole of a 25-year-old male healthy control (RR0216). Arrows indicate individual vascular mural cells. c1 Structural image of a 40 µm 
arteriole located at 5° superior to the fovea in a 26-year-old female (RR0172). c2 Corresponding motion contrast perfusion map of c1. Periarteriolar 
capillary free zone along the arteriole is clearly visualized. d1, d2 Structural image and motion contrast perfusion map of a 50 µm venule located at 
7° superior to the fovea in a 26-year-old male (RR0025). No distinct capillary free zone along the venule is observed
Page 5 of 14Chui et al. Int J Retin Vitr  (2016) 2:11 
studies must be conducted to define normative anatomic 
and physiologic standards before we can reliably assess 
disease states. In addition, comparative analyses between 
AOSLO and OCTA may be instructive regarding the sig-
nificance of vascular patterns observed and their rela-
tionship to various vascular abnormalities.
Clinical applications of retinal microvascular imaging  
using AOSLO
Currently, there are a variety of cross-sectional AOSLO 
studies which describe the structural and functional 
changes to the retinal capillaries in patients with vas-
culopathies [20, 22–25, 42–47]. This section briefly 
discusses the AOSLO imaging characteristics of three 
common retinal vasculopathies: diabetic retinopathy, ret-
inal vein occlusion, and sickle cell retinopathy. Informa-
tion obtainable using confocal and nonconfocal AOSLO 
includes foveal avascular zone geometry, vessel density, 
vascular lumen diameter, vessel wall thickness, vascular 
mural cells, capillary perfusion status, capillary tortuos-
ity, and microaneurysm morphology; all of which can 
be used to describe the variety of retinal physiologic 
and pathophysiologic processes. Examples of confocal 
AOSLO FA perfusion maps of healthy and vasculopathic 
eyes, and their corresponding colorized vessel density 
contour maps are displayed in Fig. 6.
Diabetic retinopathy
Diabetic retinopathy is the most prevalent retinal vas-
cular disease, causing visual impairments in 7.6 million 
Americans age 40 and older [48]. It typically develops 
over several years and may remain asymptomatic until 
vision-related complications occur. Clinical diagnosis 
of diabetic retinopathy has traditionally relied on the 
detection of microangiopathy such as microaneurysms, 
exudates, and hemorrhages using ophthalmoscopy, con-
ventional fundus photography, and IVFA. Histologic 
studies have shown that the onset of diabetic retinopa-
thy is characterized by pericyte loss and basement mem-
brane thickening consequent to prolonged hyperglycemia 
[49–51]. These early changes however are not visible 
with the current generation clinical imaging modalities, 
and are thus considered subclinical. A number of stud-
ies using AOSLO imaging have already demonstrated 
the ability to detect these subclinical changes in vivo [20, 
42, 43, 52]. Quantification of vascular changes is critical, 
because there is growing evidence that the retina changes 
in structure and function in aging healthy individuals and 
patients with early diabetic retinopathy [20, 30, 53, 54]. 
Using confocal AOSLO, Tam et al. showed greater arte-
riovenous tortuosity surrounding the fovea in a group 
of 15 type 2 diabetic patients without retinopathy, when 
compared to healthy controls [20]. Burns et al. evaluated 
perifoveal capillary diameters in 7 patients with mild to 
moderate non-proliferative diabetic retinopathy using 
nonconfocal AOSLO [42]. Their results demonstrated 
that with subclinical microvascular remodeling, capil-
lary diameter and arteriolar wall thickness were signifi-
cantly larger in the diabetic group when compared to 
the controls. These measureable structural changes rep-
resent potential clinical biomarkers for screening dia-
betics for early retinopathy, allowing the opportunity to 
detect changes earlier and guide better management of 
disease. Recently our group demonstrated that successful 
identification and quantification of retinal microvascu-
lar abnormalities such as microaneurysms and capillary 
dropout can be obtained using confocal AOSLO FA per-
fusion maps (Fig. 6b) [23, 25]. Dubow et al. showed that 
the combination of confocal AOSLO structural images 
and confocal AOSLO FA perfusion maps could be useful 
for evaluating retinal microaneurysm morphology and 
Fig. 3 Motion contrast perfusion map of the right eye of a 35-year-
old healthy male control generated using nonconfocal AOSLO 
registered movies. Connections between arterioles and venules are 
readily visible. Asterisk indicates the foveal avascular zone. Arterioles 
and venules are marked in red and blue, respectively. Image courtesy 
of Stephen A Burns and Dean A Vannasdale, Indiana University [30]
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geometry and for enhancing our understanding of the 
disease process [25]. Figure  7 shows a saccular microa-
neurysm imaged using different AOSLO modalities in a 
62-year-old patient with non-proliferative diabetic retin-
opathy. Microaneurysm wall structure is readily visible on 
the confocal (Fig. 7a), and nonconfocal (Fig. 7c) AOSLO 
structural images, permitting a rich survey of structural 
and functional features of microaneurysms seen with dif-
ferent techniques. While the confocal AOSLO FA perfu-
sion map shows fluorescein pooling in the stagnant end 
of the lumen (Fig. 7b), the nonconfocal AOSLO motion 
contrast perfusion map isolates the region of active blood 
flow (Fig. 7d).
Retinal vein occlusion
Retinal vein occlusion is second only to diabetic retinop-
athy as a cause of retinal vascular morbidity [55]. Branch 
retinal vein occlusion has a prevalence of 5.20 per 1000, 
being more common than central retinal vein occlusion 
[56]. Clinical presentations of retinal vein occlusion may 
range from asymptomatic to moderate or even severe loss 
of vision. Chronic vascular changes include abnormal or 
absence of perfusion distal to the point of occlusion, ves-
sel leakage, dilated collateral vessels, and neovasculariza-
tion [55, 57].
Currently, there are only few AOSLO studies on reti-
nal vascular occlusion. Using a commercially-available 
Fig. 4 Comparison of IVFA and confocal AOSLO FA perfusion map in a healthy control. Images of the right eye of a 35-year-old healthy male control 
(RR0001). a Conventional fundus photograph. b IVFA. Yellow box indicates the region imaged with confocal AOSLO FA. c Magnified IVFA compared 
to d the same region imaged with confocal AOSLO FA. c, d Reproduced with permission from Pinhas et al. [21]
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confocal AOSLO, Akagi-Kurashige et  al. observed 
that retinal capillaries were more dilated and tortuous 
in patients with branch retinal vein occlusion [58]. In 
patients with nonischemic central retinal vein occlu-
sion, Pinhas et  al. reported on the foveal vessel density 
in 4 affected and 10 fellow eyes using confocal AOSLO 
FA [24]. While vessel density of affected eyes was expect-
edly lower than that of fellow or control eyes, fellow eyes 
demonstrated vessel densities which were significantly 
reduced compared to healthy controls (Fig. 6c). This sub-
clinical vascular change observed in asymptomatic fellow 
eyes may have important implications on the pathophysi-
ology of venous occlusions and may explain the increased 
lifetime risk of occlusion in fellow eyes. Additionally, 
our recent efforts to compare confocal AOSLO FA per-
fusion maps and nonconfocal AOSLO structural images 
in patients with retinal vein occlusion have revealed an 
array of microangiopathic features such as non-perfused 
capillaries, leakage, and microaneurysms (Fig.  8), not 
fully appreciated from conventional imaging, which may 
provide additional insight into the full microanatomic 
impact of this disease.
Fig. 5 Comparison of IVFA and confocal AOSLO FA perfusion map in proliferative diabetic retinopathy. Images of the right eye of a 50-year-old male 
with proliferative diabetic retinopathy (RR0265). a Conventional fundus photograph. b IVFA shows numerous microaneurysms scattered around 
the macular region. Yellow box indicates the region imaged with confocal AOSLO FA. c Magnified IVFA compared to d the same region imaged with 
confocal AOSLO FA
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Sickle cell retinopathy
Sickle cell retinopathy is a major complication of sickle 
cell disease that can lead to visual impairment. Sickle cell 
disease is caused by a point mutation on the beta globin 
gene, which limits erythrocyte deformity and reduces 
membrane elasticity [59]. These rigid erythrocytes have 
Fig. 6 Confocal AOSLO FA perfusion maps (left column), skeletonized perfusion maps (middle column), and colorized vessel density contour maps 
(right column) in healthy and diseased retinas. a The left eye of a 25-year-old healthy male control—RR0188, b the right eye of a 50-year-old male 
with proliferative diabetic retinopathy—RR0265, c fellow eye (right eye) of a 46-year-old male with branch retinal vein occlusion—RR0272, and d 
the left eye of a 44-year-old female with sickle cell retinopathy—RR0204
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a tendency to stack and occlude small blood vessels of 
nearly any organ, including the retinal capillaries. Clinical 
presentations of non-proliferative sickle cell retinopathy 
include hemorrhages, venous tortuosity, and enlargement 
of the foveal avascular zone [60]. On the other hand, pro-
liferative sickle cell retinopathy reflects more advanced 
disease and is characterized by retinal neovascularization 
in response to ischemia following occlusion, especially 
in the peripheral retina. These new blood vessels are 
vulnerable to rupture from vitreous traction, leading to 
vitreous hemorrhage and increased risk of retinal detach-
ment [61]. Recent application of confocal AOSLO FA to 
imaging patients with sickle cell retinopathy has demon-
strated significantly higher capillary tortuosity compared 
to healthy controls [47]. Further studies exploring the 
clinical application of capillary tortuosity as a metric for 
monitoring sickle cell retinopathy progression are cur-
rently underway. Examples of increased capillary tortu-
osity and non-perfusion are shown in Fig. 6d and Fig. 9, 
respectively. Although the identification of non-perfused 
capillaries is clearly demonstrated by comparing the con-
focal AOSLO FA perfusion map and the nonconfocal 
AOSLO structural image (Fig. 9, white arrows), only the 
nonconfocal AOSLO image reveals the structural appear-
ance of the non-perfused capillaries, which are clearly 
absent from the confocal AOSLO FA perfusion map.
Fig. 7 A retinal microaneurysm in a 62-year-old female with non-
proliferative diabetic retinopathy imaged with different AOSLO 
modalities (RR0217). a Confocal AOSLO structural image, b confocal 
AOSLO FA perfusion map, c nonconfocal AOSLO structural image, and 
d nonconfocal AOSLO motion contrast perfusion map
Fig. 8 Imaging of non-perfused capillaries and microaneurysms 
in a 24-year-old male with hemiretinal vein occlusion using AOSLO 
(RR0235). a Confocal AOSLO FA perfusion map obtained at 3° superior 
to the fovea in the right eye (affected eye). b Visualization of the 
non-perfusion capillaries on nonconfocal AOSLO structural image. 
Comparison of the confocal AOSLO FA perfusion map and nonconfo-
cal AOSLO structural image reveals non-perfused capillaries (yellow 
arrows) and a microaneurysm located at the deep layer (red arrows)
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Longitudinal imaging of retinal microvasculature using 
AOSLO
As revealing as AOSLO cross-sectional imaging has 
been for displaying the details of microvascular change, 
its capability for non-invasive recording of longitudinal 
data is even more extraordinary, providing insight into 
the natural progression of microangiopathies. The ability 
to track capillary perfusion and microaneurysms longitu-
dinally allows the opportunity to develop metrics of vas-
cular change and apply them as biomarkers to help stage 
disease progression and assess treatment response [62–
66]. Figures 10 and 11 present two examples of longitu-
dinal imaging of retinal microvasculature using AOSLO, 
which demonstrate its utility in documenting dynamic 
structural and functional changes [43, 52]. 
Figure 10 shows fundus photographs and nonconfocal 
AOSLO structural images of a 55-year-old female with 
branch retinal vein occlusion of 4  years duration. She 
received segmental scatter photocoagulation in the left 
eye 4 years prior to her baseline AOSLO imaging session. 
Nonconfocal AOSLO structural images of the left eye 
were obtained at baseline, 2  months, and 7  months. 
During this period, her visual acuity in the study eye 
remained stable at 20/20. Baseline color fundus pho-
tography, IVFA, and spectral domain optical coherence 
tomography (SDOCT) images are shown in Fig.  10a–c, 
respectively. Nonconfocal AOSLO images at 2  months 
and 7  months show only minor microvascular changes 
as compared to baseline imaging (Fig. 10d, white arrows), 
suggesting that the BRVO is well-compensated with no 
progressive retinal microvasculature changes  due to 
unresolved ischemia. The nonconfocal AOSLO images 
demonstrate the consistency and repeatability of the 
technique, and its ability to capture consistent images of 
the same retinal location over time.
Longitudinal vascular imaging of a 49-year-old female 
with proliferative diabetic retinopathy is shown in Fig. 11. 
This patient had a history of diabetes mellitus type 2 con-
trolled with metformin and sitagliptin for 3  years dura-
tion. AOSLO imaging at 1° inferior retina of the right eye 
was done at baseline and 5 months. She received one bev-
acizumab injection to both eyes 2 months after baseline. 
During this period, her visual acuity changed from 20/15 
to 20/20. Her hemoglobin A1c levels were not available 
at these times. Baseline color fundus photography, IVFA, 
and SDOCT images at baseline are shown in Fig. 11a–c, 
respectively. The fundus photograph and IVFA show evi-
dence of dot-blot hemorrhages and fluorescein leakage 
with no significant changes in the OCT over the course 
of 5 months. Two distinct examples of vessel looping are 
evident at baseline in the confocal AOSLO FA and non-
confocal AOSLO images as revealed by the yellow arrows 
in Fig.  11d. Full structural regression and loss of capil-
lary patency can be seen at 5 months as indicated by the 
yellow arrows in Fig. 11e. Neighboring vessels appear to 
remain intact in the structural images and persistently 
patent in the perfusion maps over the course of 5 months. 
Our preliminary results are consistent with a previous 
study that AOSLO imaging is repeatable and sensitive 
enough to detect changes such as capillary dropout [43].
Limitations of AOSLO for clinical use
Despite the AOSLO’s extraordinary ability to extend 
our view into the microworld, current instrumentation 
and protocols have limitations that prevent its wide-
spread clinical use. It is very time-consuming to acquire 
images, due to its limited field of view, and can be very 
fatiguing for patients. Furthermore, the optics of the 
AOSLO exaggerates sensitivity to media opacities, higher 
refractive errors, fixation stability, and tear film quality, 
and demands exceptional subject cooperation. Image 
processing, montaging and analysis are also very labor 
intensive and time consuming due to lack of automated 
Fig. 9 Imaging of non-perfused blood vessels in a 24-year-old male 
with sickle cell retinopathy using AOSLO (RR0292). a Confocal AOSLO 
FA perfusion map obtained at 2° superior to the fovea in the right eye. 
Shadow of a non-perfused blood vessel is indicated by a white arrow. 
b Visualization of the non-perfusion blood vessel on nonconfocal 
AOSLO structural image. c Superimposed composite of a (in red) and 
b reveals the location of perfused and non-perfused blood vessels
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techniques. Hopefully future advances in speed and 
tracking will expand its ability to image more challenging 
eyes, and software advances will make results more rap-
idly available in a clinically relevant time course.
Conclusions
AOSLO provides unprecedented views of the retinal 
vascular network down to the capillary level, revealing 
microscopic vascular features that are not consistently 
Fig. 10 Clinical photographs and nonconfocal AOSLO images of a 55-year-old female with branch retinal vein occlusion (RR0129). a Fundus pho-
tograph of the left eye. Black arrow indicates location of horizontal SDOCT scanning. b IVFA showing tortuous blood vessels with superior temporal 
region treated with pan-retinal photocoagulation. Yellow box indicates the region imaged with nonconfocal AOSLO. c Horizontal SDOCT ~2.5° 
superior to the fovea obtained at the first AOSLO imaging visit. d Longitudinal nonconfocal AOSLO imaging performed at baseline, 2 months, and 
7 months shows only minor microvascular changes across visits (white arrows). Panel D1 was reproduced with permission from Chui et al. [22]
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Fig. 11 Clinical photographs and AOSLO images of a 49-year-old female with proliferative diabetic retinopathy (RR0167). a Fundus photograph of 
the right eye. Black arrow indicates location of horizontal foveal SDOCT scanning. b IVFA showing scattered microaneursyms and fluorescein leak-
age. Yellow box indicates the region imaged with AOSLO. c Horizontal foveal SDOCT obtained at the first AOSLO imaging visit. Longitudinal AOSLO 
imaging performed at d baseline and e 5 months. d1, e1 Confocal AOSLO FA perfusion maps. d2, e2 Nonconfocal AOSLO structural images. d3, e3 
Nonconfocal AOSLO motion contrast perfusion maps. Yellow arrows indicate capillary non-perfusion and regression over 5 months
Page 13 of 14Chui et al. Int J Retin Vitr  (2016) 2:11 
visible with current clinical ophthalmic imaging instru-
ments. This high resolution imaging technique also 
shows significant potential for studying physiological 
and pathological features of the retinal vasculature in the 
living human eye. Its ability to noninvasively track sub-
clinical vascular changes over time opens new vistas onto 
the dynamic evolution of certain diseases and provides a 
more sensitive examination of clinical interventions.
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